TW202528334A - 合成之嵌合痘病毒 - Google Patents
合成之嵌合痘病毒Info
- Publication number
- TW202528334A TW202528334A TW113144133A TW113144133A TW202528334A TW 202528334 A TW202528334 A TW 202528334A TW 113144133 A TW113144133 A TW 113144133A TW 113144133 A TW113144133 A TW 113144133A TW 202528334 A TW202528334 A TW 202528334A
- Authority
- TW
- Taiwan
- Prior art keywords
- virus
- schpxv
- dna
- scopv
- genome
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662416577P | 2016-11-02 | 2016-11-02 | |
| US62/416,577 | 2016-11-02 | ||
| US201662434794P | 2016-12-15 | 2016-12-15 | |
| US62/434,794 | 2016-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202528334A true TW202528334A (zh) | 2025-07-16 |
Family
ID=62075555
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW106137976A TWI887191B (zh) | 2016-11-02 | 2017-11-02 | 合成之嵌合痘病毒 |
| TW113144133A TW202528334A (zh) | 2016-11-02 | 2017-11-02 | 合成之嵌合痘病毒 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW106137976A TWI887191B (zh) | 2016-11-02 | 2017-11-02 | 合成之嵌合痘病毒 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11345896B2 (enExample) |
| EP (1) | EP3535389A4 (enExample) |
| JP (3) | JP2019535311A (enExample) |
| CN (1) | CN110431228B (enExample) |
| AU (2) | AU2017353868C1 (enExample) |
| BR (1) | BR112019008781A2 (enExample) |
| CA (1) | CA3042694A1 (enExample) |
| IL (2) | IL319942A (enExample) |
| MX (1) | MX2019005102A (enExample) |
| NZ (1) | NZ752893A (enExample) |
| SG (1) | SG11201903893PA (enExample) |
| TW (2) | TWI887191B (enExample) |
| WO (1) | WO2018085582A1 (enExample) |
| ZA (3) | ZA201902868B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110431228B (zh) | 2016-11-02 | 2024-04-02 | 戴维·埃文斯 | 合成嵌合痘病毒 |
| WO2018148710A1 (en) * | 2017-02-13 | 2018-08-16 | Excision Biotherapeutics, Inc. | Visualizing viral reservoirs and dissemination in vivo |
| JP2021522784A (ja) * | 2018-05-02 | 2021-09-02 | トニックス ファーマ ホールディングス リミテッド | 合成キメラワクシニアウイルス |
| US20240024393A1 (en) * | 2019-01-25 | 2024-01-25 | Virocure, Inc. | Pharmaceutical composition for preventing or treating cancer, comprising squirrel fibroma virus and reovirus |
| US20230097513A1 (en) * | 2020-02-03 | 2023-03-30 | City Of Hope | Poxvirus-based vectors produced by natural or synthetic dna and uses thereof |
| WO2021174142A1 (en) | 2020-02-26 | 2021-09-02 | Tonix Pharmaceuticals Holding Corp. | Recombinant poxvirus based vaccine against sars-cov-2 virus |
| MX2023009008A (es) | 2021-02-02 | 2023-10-05 | Geovax Inc | Constructos virales para usarse en potenciar el cebado de linfocitos t durante la vacunación. |
| WO2023168286A1 (en) | 2022-03-01 | 2023-09-07 | Tonix Pharmaceuticals Holding Corp. | Recombinant poxvirus based vaccine against the omicron strain of sars-cov-2 virus and variants thereof |
| CN117264909B (zh) * | 2023-10-25 | 2024-11-26 | 深圳湾实验室 | 反式互补缺陷猴痘病毒及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2787577A (en) | 1953-12-01 | 1957-04-02 | Lilly Co Eli | Stable smallpox vaccine |
| US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US6723325B1 (en) | 2001-04-23 | 2004-04-20 | Acambis, Inc. | Smallpox vaccine |
| US20040014034A1 (en) * | 2002-06-06 | 2004-01-22 | Evans David H | Method of producing a recombinant virus |
| US20070275010A1 (en) | 2003-09-18 | 2007-11-29 | Mark Feinberg | Mva Vaccines |
| JPWO2006022215A1 (ja) | 2004-08-23 | 2008-05-08 | 財団法人ヒューマンサイエンス振興財団 | ＳＡＲＳ−コロナウイルスタンパク質をコードするＤＮＡを保有する組換えワクチニアウイルスＤＩｓ株、およびその利用 |
| CN101020055B (zh) | 2006-02-16 | 2012-08-08 | 中国疾病预防控制中心性病艾滋病预防控制中心 | 基于复制型痘苗病毒载体的sars疫苗 |
| EP2426142A3 (en) | 2006-10-16 | 2012-06-13 | Genelux Corporation | Modified vaccinia virus strains for use in a diagnostic and therapeutic method |
| US8795667B2 (en) * | 2007-12-19 | 2014-08-05 | Macrogenics, Inc. | Compositions for the prevention and treatment of smallpox |
| FI20115914L (fi) | 2011-09-16 | 2013-03-17 | Oncos Therapeutics Ltd | Muunnettu onkolyyttinen virus |
| WO2014160475A1 (en) | 2013-03-13 | 2014-10-02 | Aboody Karen S | Tropic cell based virotherapy for the treatment of cancer |
| CN105121635B (zh) | 2013-04-10 | 2018-10-16 | 东源生物医药科技（上海）有限公司 | 突变型痘苗病毒株、其用途及其制造方法 |
| EP3045181B1 (en) | 2015-01-19 | 2018-11-14 | Ludwig-Maximilians-Universität München | A novel vaccine against the middle east respiratory syndrome coronavirus (MERS-CoV) |
| EA201800148A1 (ru) | 2015-08-11 | 2019-01-31 | Калиди Биотерапьютикс, Инк. | Оспенная вакцина для лечения рака |
| JP2019528753A (ja) | 2016-09-21 | 2019-10-17 | スティーブン エイチ． ソーン， | 高移動度グループｂｏｘｉ突然変異体 |
| CN110431228B (zh) | 2016-11-02 | 2024-04-02 | 戴维·埃文斯 | 合成嵌合痘病毒 |
| ES2702618B2 (es) | 2017-09-04 | 2019-10-31 | Inst De Salud Carlos Iii | Producto de combinación que comprende una célula madre mesenquimatosa modificada y una sustancia antigénica. |
| TW202014200A (zh) | 2018-05-02 | 2020-04-16 | 賽斯 雷德曼 | 包含合成嵌合牛痘病毒之幹細胞及其使用方法 |
| JP2021522784A (ja) | 2018-05-02 | 2021-09-02 | トニックス ファーマ ホールディングス リミテッド | 合成キメラワクシニアウイルス |
-
2017
- 2017-11-02 CN CN201780078546.0A patent/CN110431228B/zh active Active
- 2017-11-02 IL IL319942A patent/IL319942A/en unknown
- 2017-11-02 BR BR112019008781-8A patent/BR112019008781A2/pt active Search and Examination
- 2017-11-02 CA CA3042694A patent/CA3042694A1/en active Pending
- 2017-11-02 SG SG11201903893PA patent/SG11201903893PA/en unknown
- 2017-11-02 IL IL266399A patent/IL266399B2/en unknown
- 2017-11-02 MX MX2019005102A patent/MX2019005102A/es unknown
- 2017-11-02 NZ NZ752893A patent/NZ752893A/en unknown
- 2017-11-02 TW TW106137976A patent/TWI887191B/zh active
- 2017-11-02 EP EP17868045.0A patent/EP3535389A4/en active Pending
- 2017-11-02 AU AU2017353868A patent/AU2017353868C1/en active Active
- 2017-11-02 JP JP2019545700A patent/JP2019535311A/ja active Pending
- 2017-11-02 WO PCT/US2017/059782 patent/WO2018085582A1/en not_active Ceased
- 2017-11-02 TW TW113144133A patent/TW202528334A/zh unknown
- 2017-11-02 US US15/802,189 patent/US11345896B2/en active Active
-
2019
- 2019-05-07 ZA ZA2019/02868A patent/ZA201902868B/en unknown
-
2022
- 2022-05-06 ZA ZA2022/04981A patent/ZA202204981B/en unknown
- 2022-05-27 US US17/827,320 patent/US12365879B2/en active Active
- 2022-09-02 JP JP2022140113A patent/JP2022164900A/ja not_active Withdrawn
-
2024
- 2024-02-15 AU AU2024200997A patent/AU2024200997A1/en not_active Abandoned
- 2024-05-02 ZA ZA2024/03393A patent/ZA202403393B/en unknown
- 2024-06-10 JP JP2024093677A patent/JP2024107257A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US12365879B2 (en) | 2025-07-22 |
| EP3535389A4 (en) | 2020-06-03 |
| IL319942A (en) | 2025-05-01 |
| CN110431228A (zh) | 2019-11-08 |
| AU2017353868B2 (en) | 2024-02-29 |
| WO2018085582A1 (en) | 2018-05-11 |
| AU2017353868C1 (en) | 2024-06-06 |
| NZ752893A (en) | 2025-10-31 |
| ZA201902868B (en) | 2022-12-21 |
| CA3042694A1 (en) | 2018-05-11 |
| SG11201903893PA (en) | 2019-05-30 |
| IL266399B2 (en) | 2025-09-01 |
| ZA202403393B (en) | 2025-08-27 |
| EP3535389A1 (en) | 2019-09-11 |
| US20180251736A1 (en) | 2018-09-06 |
| IL266399B1 (en) | 2025-05-01 |
| AU2017353868A1 (en) | 2019-05-16 |
| JP2019535311A (ja) | 2019-12-12 |
| AU2024200997A1 (en) | 2024-03-07 |
| JP2024107257A (ja) | 2024-08-08 |
| JP2022164900A (ja) | 2022-10-27 |
| CN110431228B (zh) | 2024-04-02 |
| TWI887191B (zh) | 2025-06-21 |
| MX2019005102A (es) | 2019-10-30 |
| US20230002741A1 (en) | 2023-01-05 |
| ZA202204981B (en) | 2024-09-25 |
| TW201819400A (zh) | 2018-06-01 |
| BR112019008781A2 (pt) | 2019-07-16 |
| US11345896B2 (en) | 2022-05-31 |
| IL266399A (en) | 2019-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017353868C1 (en) | Synthetic chimeric poxviruses | |
| DK3209381T3 (en) | COMPOSITIONS COMPREHENSIVE BAKERY STUES | |
| KR102243727B1 (ko) | 유전자 표적화 및 형질 스태킹을 위한 조작된 트랜스진 통합 플랫폼 (etip) | |
| CN108138122B (zh) | 免疫调控 | |
| AU2013312198B2 (en) | Fluorescence activated cell sorting (FACS) enrichment to generate plants | |
| CN114555793B (zh) | 基于基因i177l缺失的新型非洲猪瘟减毒活疫苗的开发 | |
| CN112543806B (zh) | 合成嵌合痘苗病毒 | |
| KR20210132002A (ko) | 변형된 오르토폭스 바이러스 벡터 | |
| CN116348135A (zh) | 基于重组痘病毒的抗SARS-CoV-2病毒疫苗 | |
| JPH09322781A (ja) | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓポリヌクレオチドおよび配列 | |
| CN113151310B (zh) | 非洲猪瘟基因缺失弱毒株的构建及其作为疫苗的应用 | |
| KR101234062B1 (ko) | 림프구 내 유전자 도입용 재조합 바이러스 벡터 | |
| JPH09252787A (ja) | マイコプラズマ・ジェニタリウムゲノムまたはその断片のヌクレオチド配列およびその使用 | |
| KR20220148823A (ko) | 천연 또는 합성 dna에 의해 생산된 폭스바이러스-기반 벡터 및 그의 용도 | |
| KR20230012583A (ko) | 합성 변형된 백시니아 앙카라 (sMVA) 기반 코로나바이러스 백신 | |
| KR20240021274A (ko) | 반코마이신 내성 장구균에 대한 박테리오파지 | |
| KR102064765B1 (ko) | 병원성 대장균의 증식을 억제하는 신규 박테리오파지 및 이의 용도 | |
| AU775084B2 (en) | Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof | |
| KR20230136600A (ko) | 안정적인 세포주에서 효율적인 성장을 가능하게 하는아프리카 돼지 열병 백신의 게놈 결실 | |
| CN109517069A (zh) | 一种用于表达Bt杀虫蛋白的高效蛋白质表达系统 | |
| AU2018256922B2 (en) | Targeted gene disruption methods and immunogenic compositions | |
| CN112261951A (zh) | 包含合成嵌合痘苗病毒的干细胞及其使用方法 | |
| TWI902763B (zh) | 基於重組痘病毒之抗SARS-CoV-2病毒疫苗 | |
| JP2001292771A (ja) | アブラムシ共生バクテリアのゲノムｄｎａ | |
| KR101635497B1 (ko) | 종자수가 감소한 신품종 수박 및 이의 육종 방법 |